VivoSeq
Respiratory

Sarcoidosis, Pulmonary

2

Pipeline Programs↗

1

Active Trials↗

1

Companies Involved↗

Sarcoidosis, Pulmonary is an early-stage landscape with 2 programs across 1 company. The most active players are Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd..

Intelligence

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

6/100

Mech. Concentration

100/100

Completion Rate

N/A

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

S

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

1 program

Preclinical

Pipeline

Programs by Phase

Preclinical2

Prednisone

Roxane Laboratories

Compound Betamethasone

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Approved
No programs

Analysis

Trial Status

1

clinical trials

Not yet recruiting1 · 100%

Clinical Trials

Trial Activity

A Prospective, Multi-center, Randomized Controlled Clinical Trial to Evaluate the Efficacy and Safety of Compound Betamethasone in Pulmonary Sarcoidosis
Not yet recruiting·PPeking Union Medical College Hospital·Preclinical·NCT07668895·126 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)